Clinical Trial TitleA Study of SARS CoV-2 Infection and Potential Transmission in Individuals Immunized With Moderna COVID-19 Vaccine (CoVPN 3006)
National Clinical Trial Number:NCT04811664
Clinical Trial Protocol Description:
The purpose of this study is to assess SARS CoV-2 infection, viral shedding, and subsequent potential transmission in individuals immunized with the Moderna COVID-19 vaccine versus those who delay immunization or choose not to get immunized.
Clinical Trial Eligibility Criteria:
In order to participate you must meet the following criteria:
- Are 18 to 29 years of age.
You will be excluded from the study if any of the following criteria apply to you:
- Have a history of a COVID-19 infection.
- Have a previous COVID-19 vaccination of any kind.
This is a partial list of eligibility requirements. To inquire about your eligibility, please call the contact number provided. If you wish to inquire via email, please include the title of the study in your message.